JMPWA
ALBO

JP Morgan Private Wealth Advisors’s Albireo Pharma Inc ALBO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,940
Closed -$209K – 2002
2021
Q2 		$209K Sell
5,940
-116
-2% -$3.77K ﹤0.01% 1822
2021
Q1 		$213K Buy
+6,056
New +$224K ﹤0.01% 1664

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

JP Morgan Private Wealth Advisors's ALBO Position: Q3 2021 in Review

JP Morgan Private Wealth Advisors sold out of Albireo Pharma Inc (ALBO) in Q3 2021, closing a stake of 5,940 shares — an estimated $209K sold.

JP Morgan Private Wealth Advisors first reported a position in ALBO in Q1 2021 and held it in 2 quarters. The position peaked at $213K in Q1 2021. 94 funds tracked by Wall St. Rank hold ALBO as of Q3 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Albireo Pharma Inc position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 5,940 Albireo Pharma Inc shares in Q3 2021, an estimated $209K.
  • JP Morgan Private Wealth Advisors first reported a position in Albireo Pharma Inc in Q1 2021 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Albireo Pharma Inc position peaked at $213K in Q1 2021.
  • 94 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q3 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.